Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 164

1.

Granulocyte transfusions in severe aplastic anemia: an eleven-year experience.

Quillen K, Wong E, Scheinberg P, Young NS, Walsh TJ, Wu CO, Leitman SF.

Haematologica. 2009 Dec;94(12):1661-8. doi: 10.3324/haematol.2009.010231.

2.

Granulocyte transfusion combined with granulocyte colony stimulating factor in severe infection patients with severe aplastic anemia: a single center experience from China.

Wang H, Wu Y, Fu R, Qu W, Ruan E, Wang G, Liu H, Song J, Xing L, Guan J, Li L, Liu C, Shao Z.

PLoS One. 2014 Feb 5;9(2):e88148. doi: 10.1371/journal.pone.0088148.

3.

Controlled study of therapeutic granulocyte transfusions in granulocytopenic patients with severe infections.

Matsue K, Harada M, Nakao S, Ueda M, Kondo K, Odaka K, Mori T, Hattori K.

Jpn J Clin Oncol. 1984 Mar;14(1):21-30.

PMID:
6368906
4.

Treatment of adults with severe aplastic anemia: primary therapy with antithymocyte globulin (ATG) and rescue of ATG failures with bone marrow transplantation.

Crump M, Larratt LM, Maki E, Curtis JE, Minden MD, Meharchand JM, Lipton JH, Messner HA.

Am J Med. 1992 Jun;92(6):596-602.

PMID:
1605140
5.

Antilymphocyte globulin, cyclosporin, and granulocyte colony-stimulating factor in patients with acquired severe aplastic anemia (SAA): a pilot study of the EBMT SAA Working Party.

Bacigalupo A, Broccia G, Corda G, Arcese W, Carotenuto M, Gallamini A, Locatelli F, Mori PG, Saracco P, Todeschini G, et al.

Blood. 1995 Mar 1;85(5):1348-53.

6.
7.

Treatment of severe aplastic anemia with antilymphocyte globulin, cyclosporine and two different granulocyte colony-stimulating factor regimens: a GITMO prospective randomized study.

Locasciulli A, Bruno B, Rambaldi A, Saracco P, Dufour C, Finelli C, Sica S, Varotto S, Arcese W, Locatelli F, Soligo D, Bacigalupo A; GITMO prospective randomized study..

Haematologica. 2004 Sep;89(9):1054-61.

8.

Comparison between horse and rabbit antithymocyte globulin as first-line treatment for patients with severe aplastic anemia: a single-center retrospective study.

Atta EH, Dias DS, Marra VL, de Azevedo AM.

Ann Hematol. 2010 Sep;89(9):851-9. doi: 10.1007/s00277-010-0944-y.

PMID:
20373101
9.

Safety and efficacy of therapeutic early onset granulocyte transfusions in pediatric patients with neutropenia and severe infections.

Sachs UJ, Reiter A, Walter T, Bein G, Woessmann W.

Transfusion. 2006 Nov;46(11):1909-14.

PMID:
17076845
10.
11.
12.

Recombinant interferon gamma1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions.

Safdar A, Rodriguez GH, Lichtiger B, Dickey BF, Kontoyiannis DP, Freireich EJ, Shpall EJ, Raad II, Kantarjian HM, Champlin RE.

Cancer. 2006 Jun 15;106(12):2664-71.

14.

Granulocyte transfusions: efficacy in treating fungal infections in neutropenic patients following bone marrow transplantation.

Bhatia S, McCullough J, Perry EH, Clay M, Ramsay NK, Neglia JP.

Transfusion. 1994 Mar;34(3):226-32.

PMID:
8146895
15.

Efficacy of granulocyte transfusions for neutropenia-related infections: retrospective analysis of predictive factors.

Rutella S, Pierelli L, Sica S, Serafini R, Chiusolo P, Paladini U, Leone F, Zini G, D'Onofrio G, Leone G, Piccirillo N.

Cytotherapy. 2003;5(1):19-30.

PMID:
12745586
16.

Invasive fungal sinusitis in patients undergoing bone marrow transplantation.

Drakos PE, Nagler A, Or R, Naparstek E, Kapelushnik J, Engelhard D, Rahav G, Ne'emean D, Slavin S.

Bone Marrow Transplant. 1993 Sep;12(3):203-8. Review.

PMID:
8241977
17.

Fusarium infections in patients with severe aplastic anemia: review and implications for management.

Girmenia C, Iori AP, Boecklin F, Torosantucci A, Chiani P, De Fabritiis P, Taglietti F, Cassone A, Martino P.

Haematologica. 1999 Feb;84(2):114-8. Review.

18.

Granulocyte transfusion therapy: randomization after all?

Drewniak A, Kuijpers TW.

Haematologica. 2009 Dec;94(12):1644-8. doi: 10.3324/haematol.2009.013680. No abstract available.

19.

Predictors of response to immunosuppressive therapy with antithymocyte globulin and cyclosporine and prognostic factors for survival in patients with severe aplastic anemia.

Chang MH, Kim KH, Kim HS, Jun HJ, Kim DH, Jang JH, Kim K, Jung CW.

Eur J Haematol. 2010 Feb 1;84(2):154-9. doi: 10.1111/j.1600-0609.2009.01378.x.

PMID:
19912311
20.

Durable treatment-free remission after high-dose cyclophosphamide therapy for previously untreated severe aplastic anemia.

Brodsky RA, Sensenbrenner LL, Smith BD, Dorr D, Seaman PJ, Lee SM, Karp JE, Brodsky I, Jones RJ.

Ann Intern Med. 2001 Oct 2;135(7):477-83.

PMID:
11578150
Items per page

Supplemental Content

Support Center